文献速递临床试验与 GCP新药、器械与细胞基因治疗研发

磷丙泊酚二钠与丙泊酚在老年TURP患者镇静有效性与围术期安全性的随机对照试验研究方案

Evaluating sedation efficacy and perioperative safety of fospropofol disodium versus propofol in elderly patients undergoing elective TURP: study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2026-08-24

BACKGROUND: Fospropofol disodium is the first novel water-soluble propofol prodrug in China. After administration, it is mainly converted to propofol by alkaline phosphatase on the surface of endothelial cells to exert its pharmacological effects.…

要点

  • 磷丙泊酚二钠是新型水溶性丙泊酚前药,经碱性磷酸酶转化为丙泊酚起效。
  • 主要结局为镇静成功率和镇静起效时间,次要结局包括围术期指标、血流动力学及不良反应。

核心结论

  • 该研究方案旨在评估磷丙泊酚二钠在老年患者择期TURP常规麻醉诱导与维持中的安全性和有效性。
  • 通过比较磷丙泊酚二钠与丙泊酚的镇静成功率和起效时间,为老年人群全麻用药提供新指导。

研究设计与样本

  • 麻醉诱导:E组静注丙泊酚1-1.5 mg/kg,F组静注磷丙泊酚二钠10-15 mg/kg,均在60秒内输注完毕;当MOAA/S评分降至1且BIS<60持续≥3分钟时行气管插管。
  • 麻醉维持:E组持续静注丙泊酚4-12 mg/(kg·h)和瑞芬太尼0.2-0.4 µg/(kg·min);F组持续静注磷丙泊酚二钠10-20 mg/(kg·h)和瑞芬太尼0.2-0.4 µg/(kg·min)。
  • 术中根据血流动力学调整维持麻醉输注速率,维持血压和心率波动在基线值20%以内,BIS值维持在40-60。

关键数值与推荐

  • 主要结局:镇静成功率和镇静起效时间。
  • 次要结局:围术期指标、各时间点血流动力学指标、不良反应。
  • 诱导时联合使用舒芬太尼0.2-0.4 µg/kg和顺苯磺酸阿曲库铵0.15 mg/kg静脉注射。

临床怎么用

  • 该研究为方案报告,尚未提供临床实践推荐;若结果证实磷丙泊酚二钠安全有效,可能为老年患者全麻诱导与维持提供新的用药选择。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Fospropofol disodium is the first novel water-soluble propofol prodrug in China. After administration, it is mainly converted to propofol by alkaline phosphatase on the surface of endothelial cells to exert its pharmacological effects. Compared with propofol, fospropofol disodium has the characteristics of longer duration of action, lower incidence of injection pain and adverse events related to the respiratory and circulatory systems, and no adverse reactions related to lipid metabolism. At present, there are few reports on the safety and efficacy of fospropofol disodium in the induction and maintenance of general anesthesia. Therefore, this study aims to evaluate the safety and efficacy of fospropofol disodium in routine anesthesia for elective surgery in the elderly, so as to provide new medication guidance for its application in the induction and maintenance stages of general anesthesia in the elderly population. METHODS: Seventy elderly patients aged 65-85 years with American Society of Anesthesiologists (ASA) physical status II or III, scheduled for elective transurethral resection of the prostate under general anesthesia, will be enrolled. Patients will be randomly divided into the propofol group (group E) and the fospropofol disodium group (group F) using a random number table, with 35 cases in each group. Anesthesia induction: sufentanil 0.2-0.4 µg/kg and cisatracurium besilate 0.15 mg/kg will be administered intravenously. Group E will receive an intravenous bolus of propofol 1-1.5 mg/kg, while group F will receive an intravenous bolus of fospropofol disodium 10-15 mg/kg, both infused within 60 s. Tracheal intubation will be performed when the patient's Modified Observer's Assessment of Alertness/Sedation (MOAA/S) score decreases to 1 with BIS < 60 sustained for ≥3 min, followed by routine mechanical ventilation. For anesthesia maintenance, group E will receive continuous intravenous infusion of propofol 4-12 mg/(kg·h) and remifentanil 0.2-0.4 µg/(kg·min) via a syringe pump; group F will receive continuous intravenous infusion of fospropofol disodium 10-20 mg/(kg·h) and remifentanil 0.2-0.4 µg/(kg·min) via a syringe pump. During the operation, the infusion rates of maintenance anesthetics will be adjusted according to hemodynamic status to maintain blood pressure and heart rate fluctuations within 20% of the baseline values, and the Bispectral Index (BIS) value will be maintained between 40 and 60. After the operation, patients will be transferred to the post-anesthesia care unit (PACU). Primary outcomes of this study: success rate of sedation and time to onset of sedation. SECONDARY OUTCOMES: (1) perioperative indicators, (2) hemodynamic indices at each time point, (3) adverse reactions. DISCUSSION: Elderly patients undergoing transurethral resection of the prostate (TURP) are often complicated with multiple comorbidities, leading to a relatively high anesthetic risk. This trial takes the success rate of sedation and time to onset of sedation as the primary endpoints, to compare the application differences between fospropofol disodium and propofol. The aim of this study is to evaluate the safety and efficacy of fospropofol disodium in routine anesthesia for elective surgeries in the elderly population. TRIAL REGISTRATION: The study was registered at the Chinese Clinical Trials Registry (ChiCTR2500115343) on December 24, 2025 ( http://www.chictr.org.cn/showproj.html?proj=294899 ).

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Sui H, Wu T, Gao L, et al. Evaluating sedation efficacy and perioperative safety of fospropofol disodium versus propofol in elderly patients undergoing elective TURP: study protocol for a randomized controlled trial. Trials. 2026. PMID: 42870298. doi:10.1186/s13063-026-09957-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。